Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Cronos Group CRON, +1.13% said Tuesday its fourth-quarter loss increased to $133.89 million, or 36 cents a share, from $111.71 million, or 31 cents a share, in the year-ago quarter. Net revenue increased to $25.8 million from $17.05 million.

Cronos Group loss widens, revenue beats target

Consolidated net revenue increased 59% in Full Year 2021 compared to Full Year 2020

Cronos Group Reports 2021 Fourth Quarter and Full-Year Results

TORONTO, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Fourth Quarter and Full-year Earnings Conference Call on Tuesday, March 1, 2022 at 8:30 a.m. ET. Cronos Group's senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2021 Fourth Quarter and Full-Year Earnings Conference Call on March 1, 2022

Cronos Group Inc.'s (CRON) CEO Kurt Schmidt on Q3 2021 Results - Earnings Call Transcript

OAKLAND, Calif.--(BUSINESS WIRE)---- $CRON #CRON--Gibbs Law Group is investigating potential claims on behalf of Cronos Group investors.

Lost Money in Cronos Group, Inc.?

Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) announced its 2021 third-quarter business results, revealing net revenue of $20.4 million, compared to $11.4 million in the same period of 2020. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, increased sales in the Israeli medical cannabis market and increased sales in the U.S. segment.

Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation

Cronos Group CRON, -4.77% CRON, -4.59% said Friday its third-quarter net income fell to $55.1 million, or 21 cents a share, from $95.2 million, or 18 cents a share, in the year-ago period. The latest quarter includes a $132.9 million gain on revaluation of derivative liabilities.

Cronos Group net income falls, launches cost-cutting measures

Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements

Cronos Group Reports 2021 Third Quarter Results

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Third Quarter Earnings Conference Call on Friday, February 18, 2022 at 8:30 a.m. EST. Cronos Group's senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2021 Third Quarter Earnings Conference Call on February 18, 2022

On November 9, 2021, the company announced that it applied for a management cease trade order with the applicable securities regulatory authorities in Canada on the basis that the company would be unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2021 with the U.S. Securities and Exchange Commission, together with its corresponding quarterly filings in Canada, by the applicable filing deadlines. The MCTO was issued on November 16, 2021 and restricts all trading in securities of the company, whether direct or indirect, by the CEO and CFO of the company until two full business days following the filing of therequired filings and the MCTO has been revoked.

Cronos Group Provides Bi-Weekly MCTO Status Update

OrganiGram Holdings Inc.

Village Farms International

Will Canadian Pot Stocks See Upside In Q1 2022? The post Canadian Marijuana Stocks On The Nasdaq For Your Watchlist In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks On The Nasdaq For Your Watchlist In February 2022

Aurora Cannabis

Canopy Growth

Tilray Brands

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag

Cannabis industry expert Alan Brochstein on 2022 catalysts.

Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)

Inovio Pharmaceuticals

These companies wouldn't be worth a second look, even in a less volatile market.

2 Stocks to Avoid Like the Plague in 2022

HEXO Corp

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starting to hit its stride.”

Cannabis Watch: Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray's price target

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Altria

Constellation Brands

Trulieve Cannabis Corp.

While the U.S. pot growers had an amazing 2021, dark clouds loomed over their Canadian counterparts.

Canadian Pot Stocks Had a Disappointing Year. Will 2022 Be Better?

Canadian cannabis company Cronos Group (NASDAQ:CRON) promoted John Griese, former chief operating officer of The Supreme Cannabis Co., as senior vice president, head of North American operations, reported Marijuana Business Daily. The Toronto-headquartered company provided no official press release on the management change, though the move was reported in a regulatory filing last week.

Cronos Promotes John Griese, Former Exec At Nestlé, PepsiCo And Supreme Cannabis

SNDL Inc.

Despite marijuana being a fast-growing industry, these cannabis stocks are buzzkills.

4 Pot Stocks to Avoid Like the Plague in 2022

NewLake Capital Partners, Inc.

Turning Point Brands

Whether federal reform happens in 2022, or if it gets delayed once more, pot plays could still become smoking hot again throughout this year. Here are seven marijuana stocks, all of which may be set to experience high times.

7 Marijuana Stocks to Buy Today for Blazing Profits

The marijuana sector is full of exciting stocks, but these two should be avoided.

2 Pot Stocks To Flat Out Avoid in 2022

BTCS

Hive Blockchain Technologies Ltd

Hecla Mining

ObsEva

Transocean

Electrameccanica

These penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months. The post 7 Penny Stocks to Buy for January appeared first on InvestorPlace.

7 Penny Stocks to Buy for January

The company delayed the release of an SEC filing and got dragged down by the broad downturn in cannabis stocks.

Why Cronos Group Stock Slumped 14% in December

Best Canadian Pot Stocks For January 2022 The post Best Canadian Marijuana Stocks For Your January 2022 Watchlist Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks For Your January 2022 Watchlist Right Now

New York, New York--(Newsfile Corp. - December 30, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs...

Rosen, a Highly Recognized Law Firm, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

This article by Johnny Green was originally published on Cannabis & Tech Today, and appears here with permission. The cost of cannabis flower has fluctuated throughout the years.

News for Cronos Group Stock (CRON)